Drug details

Herzuma (trastuzumab-pkrb for injection)

type of Antineoplastics, Anti-HER2

Herzuma (trastuzumab-pkrb) is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer. Herzuma (trastuzumab-pkrb) is biosimilar to Herceptin (trastuzumab).

This drug may have the following side effects:

• nausea,
• diarrhea,
• fever,
• chills,
• headache,
• insomnia,
• infection,
• rash.
• cough, and
• congestive heart failure,

The following drugs are related to Herzuma, either as a replacement or used together:

• Verzenio (abemaciclib tablets)
• Abraxane (albumin-bound paclitaxel for injectable suspension)
• Afinitor (everolimus tablets)
• Afinitor Disperz (everolimus tablets)
• Arimidex (anastrozole)
• Faslodex (fulvestrant)
• Zoladex 10.8 mg (goserelin acetate implant)
• Zoladex 3.6 (goserelin acetate implant)
• Herceptin (trastuzumab)
• Ibrance (palbociclib capsules for oral administration)
• Ixempra (ixabepilone)
• Tykerb (lapatinib)
• Lynparza (olaparib capsules for oral administration)
• Nolvadex (tamoxifen citrate)
• Paclitaxel Tablets (paclitaxel)
• Trodelvy (sacituzumab govitecan-hziy for injection, for iv use)
• Soltamox (tamoxifen citrate)
• Thiotepa (thiotepa injection)
• Tukysa (tucatinib tablets)